Results 211 to 220 of about 5,838,160 (343)

A survey on routing protocols for wireless sensor networks

Ad hoc networks, 2005
Kemal Akkaya, M. Younis
semanticscholar   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension

Journal of the American Medical Association (JAMA), 2018
M. Calvert, D. Kyte, R. Mercieca-Bebber, A. Slade, A. Chan, M. King, Amanda Hunn, A. Bottomley, A. Regnault, C. Ells, D. O’Connor, D. Revicki, D.walaa badawy, D. Altman, E. Basch, G. Velikova, G. Price, H. Draper, J. Blazeby, Jane A. Scott, J. Coast, J. Norquist, Julia M. Brown, K. Haywood, L. Johnson, L. Campbell, L. Frank, Maria von Hildebrand, M. Brundage, M. Palmer, P. Kluetz, R. Stephens, R. Golub, S. Mitchell, T. Groves   +34 more
semanticscholar   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

MIRD Pamphlet No. 34, Part 1: MIRDct-A Customizable Software Tool for CT Dosimetry. [PDF]

J Nucl Med
Ocampo Ramos JC, Kofler C, Dawson R, Baggett J, Dinwiddie LE, Domal SJ, Carter LM, Marquis H, Kayal G, Zanzonico PB, Bolch WE, Kesner AL.   +11 more
europepmc   +1 more source

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.

New England Journal of Medicine, 2017
J. Woodcock, L. LaVange
semanticscholar   +1 more source

Overview of molecular signatures of senescence and associated resources: pros and cons

FEBS Open Bio, EarlyView.
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas, Sylvia Vagena, Pavlos Pantelis, Giorgos Theocharous, Russel Petty, Konstantinos Evangelou, Vassilis G. Gorgoulis   +6 more
wiley   +1 more source

Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review. [PDF]

Br J Radiol
Albano D, Garziano S, Zanardo M, Ghilardi G, Casale C, Gitto S, Messina C, Vanzulli A, Sconfienza LM.   +8 more
europepmc   +1 more source

Targeting TNBC: core–shell polycationic polyurea dendrimers with inherent anticancer activity

FEBS Open Bio, EarlyView.
Core–shell polycationic PURE dendrimers were tested in TNBC‐derived tumor models. Both formulations selectively targeted TNBC and effectively reduced tumor volume. PUREG4‐OEI48 suppressed tumor growth without detectable toxicity, whereas PUREG4‐OCEI24, despite showing efficacy, induced hepatic toxicity.
Adriana Cruz, Bruna Abreu, Cindy Mendes, Catarina Freitas‐Dias, Filipe Gonçalves, Fernanda Silva, José Ramalho, Saudade André, Vasco D. B. Bonifácio, Jacinta Serpa   +9 more
wiley   +1 more source

The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial

JAMA psychiatry, 2017
D. Barlow, T. Farchione, J. Bullis, M. Gallagher, Heather Murray-Latin, S. Sauer‐Zavala, K. Bentley, Johanna Thompson-Hollands, Laren R. Conklin, James F. Boswell, Amantia A. Ametaj, Jenna R Carl, Hannah T. Boettcher, Clair F. Cassiello-Robbins   +13 more
semanticscholar   +1 more source